1.30	CX-516	CX-516	CX-516 is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator and is being developed by a collaboration of Cortex and Shire and Servier. It was researched as a treatment for Alzheimer's disease under the brand name Ampalex, and was also being examined as a treatment for ADHD.	http://upload.wikimedia.org/wikipedia/commons/thumb/9/99/CX-516-2D-skeletal.svg/220px-CX-516-2D-skeletal.svg.png
